- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Heron Therapeuti (HRTX)
Heron Therapeuti stock price live, this page displays NASDAQ HRTX stock exchange data. View the HRTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Heron Therapeuti real time stock price chart below.
What Is the Heron Therapeuti Stock Price Today?
The Heron Therapeuti stock price today is 0.959.
What Is the Stock Symbol for Heron Therapeuti?
The stock ticker symbol for Heron Therapeuti is HRTX.
Is HRTX the Same as $HRTX?
$HRTX is a common way to refer to the Heron Therapeuti ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Heron Therapeuti Trade On?
Heron Therapeuti is listed and trades on the NASDAQ stock exchange.
Is Heron Therapeuti a Good Stock to Buy?
Determining whether Heron Therapeuti—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Heron Therapeuti share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HRTX quote. (ISIN: US4277461020)
What Is the Heron Therapeuti Stock Price Today?
The Heron Therapeuti stock price today is 0.959.
What Is the Stock Symbol for Heron Therapeuti?
The stock ticker symbol for Heron Therapeuti is HRTX.
Is HRTX the Same as $HRTX?
$HRTX is a common way to refer to the Heron Therapeuti ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Heron Therapeuti Trade On?
Heron Therapeuti is listed and trades on the NASDAQ stock exchange.
Is Heron Therapeuti a Good Stock to Buy?
Determining whether Heron Therapeuti—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Heron Therapeuti share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HRTX quote. (ISIN: US4277461020)
0.959
+0.022(+2.37%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.940
0.965
52 wk Range
0.736
2.610
HRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9400.965
52 wk Range
0.7362.610
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HRTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
4.333
Upside
+351.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form DEF 14A Heron Therapeuti For: 22 December
- Investing.com
- Form 8K Heron Therapeuti For: 9 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. Heron Therapeutics, Inc. was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. The company was founded in 1983 and is headquartered in Cary, North Carolina.
Heron Therapeuti Earnings Call Summary for Q4/2025
- Heron Therapeutics reported FY 2025 net revenues of $154.9M with acute care sales surging 57% YoY; Q4 acute care grew 33% sequentially to $16.3M.
- Adjusted EBITDA reached $14.7M, exceeding guidance by up to $5.7M, with gross margin of approximately 73% reflecting improved cost efficiency.
- Oncology supportive care revenue declined 7.8% for full year due to planned wind-down of SUSTOL product line.
- Company projects 2026 net product sales of $173M-$183M; plans to expand commercial team in key markets to accelerate growth momentum.
- Shares jumped 12.04% in pre-market trading to $1.21 following strong results and successful refinancing that improved financial flexibility.
Last Updated: 02/26/2026, 09:20 AM
Read Full TranscriptHeron Therapeuti investor slides for Q4/2025
Last Update: Feb 26, 2026
See full investor slides
Compare HRTX to Peers and Sector
Metrics to compare | HRTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHRTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.9x | 17.0x | −0.5x | |
PEG Ratio | 0.24 | 0.31 | 0.00 | |
Price / Book | 13.5x | 2.5x | 2.6x | |
Price / LTM Sales | 1.2x | 4.9x | 3.2x | |
Upside (Analyst Target) | 323.7% | 112.4% | 47.6% | |
Fair Value Upside | Unlock | 10.4% | 6.1% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.333
(+351.86% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-0.02 / -0.02
Revenue / Forecast
40.59M / 39.83M
People Also Watch
FAQ
What Is the Heron Therapeuti (HRTX) Stock Price Today?
The Heron Therapeuti stock price today is 0.959 USD.
What Stock Exchange Does Heron Therapeuti Trade On?
Heron Therapeuti is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Heron Therapeuti?
The stock symbol for Heron Therapeuti is "HRTX."
What Is the Heron Therapeuti Market Cap?
As of today, Heron Therapeuti market cap is 180.050M USD.
What Is Heron Therapeuti's Earnings Per Share (TTM)?
The Heron Therapeuti EPS (TTM) is -0.121.
When Is the Next Heron Therapeuti Earnings Date?
Heron Therapeuti will release its next earnings report on May 11, 2026.
From a Technical Analysis Perspective, Is HRTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Heron Therapeuti Stock Split?
Heron Therapeuti has split 2 times.
How Many Employees Does Heron Therapeuti Have?
Heron Therapeuti has 128 employees.
What is the current trading status of Heron Therapeuti (HRTX)?
As of Apr 15, 2026, Heron Therapeuti (HRTX) is trading at a price of 0.959 USD, with a previous close of 0.937 USD. The stock has fluctuated within a day range of 0.940 USD to 0.965 USD, while its 52-week range spans from 0.736 USD to 2.610 USD.
What Is Heron Therapeuti (HRTX) Price Target According to Analysts?
The average 12-month price target for Heron Therapeuti is 4.333 USD, with a high estimate of 6 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +351.86% Upside potential.
What Is the HRTX Premarket Price?
HRTX's last pre-market stock price is 0.940 USD. The pre-market share volume is 1,770.000, and the stock has decreased by 0.003, or 0.320%.
What Is the HRTX After Hours Price?
HRTX's last after hours stock price is 0.960 USD, the stock has decreased by 0.023, or 2.430%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.